研究

Doets AY, Walgaard C, Lingsma HF, Islam B, Papri N, Yamagishi Y, Kusunoki S, Dimachkie MM, Waheed W, Kolb N, Gorson KC, Jacobs BC; IGOS Consortium.

International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score.

Oda I, Danno D, Saigoh K, Wolf J, Kawashia N, Hirano M, Samukawa M, Kitamura S, Kikui S, Takeshima T, Mitsui Y, Kusunoki S, Nagai Y.

Hemiplegic migraine type 2 with new mutation of the ATP1A2 gene in Japanese cases.

Naito T, Tsuchida N, Kusunoki S, Kaneko Y, Tobita M, Hori S, Ito S.

Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan:
a prospective observational study.

Fujii K., Hirano M, Terayama A, Inada R, Saito Y, Nishino I, Nagai Y.

Identification of a novel mutation and genotype-phenotype relationship in MEGF10 myopathy.

Hatanaka Y , Umeda T , Shigemori K , Takeuchi T , Nagai Y , Tomiyama T.

C9orf72 hexanucleotide repeat expansion-related neuropathol-2 ogy is attenuated by nasal rifampicin in mice.

Zhang X , Takeuchi T , Takeda A , Mochizuki H , Nagai Y.

Comparison of serum and plasma as a source of blood EVs: elevated levels of platelet-derived particles in serum confer difference from plasma.

Leonhard SE, van der Eijk A A, Andersen H, Antonini G, Arends S, Attarian S, Barroso FA, Bateman KJ, Batstra MR, Benedetti L, van den Berg B, Van den Bergh P, Bürmann J, Busby M, Casasnovas C, Cornblath DR, Davidson A, Doets AY, van Doorn PA, Dornonville de la Cour C, Feasby TE, Fehmi J, Garcia-Sobrino T, Goldstein JM, Gorson KC, Granit V, Hadden RDM, Harbo T, Hartung HP, Hasan I, Holbech JV, Holt JKL, Jahan I, Islam Z, Karafiath S, Katzberg HD, Kleyweg RP, Kolb N, Kuitwaard K, Kuwahara M, Kusunoki S, Luijten LWG, Kuwabara S, Lee Pan E, Lehmann HC, Maas M, Martín-Aguilar L, Miller JAL, Mohammad QD, Monges S, Nedkova-Hristova V, Nobile-Orazio E, Pardo J, Pereon Y, Querol L, Reisin R, Van Rijs W, Rinaldi S, Roberts RC, Roodbol J, Shahrizaila N, Sindrup SH, Stein B, Cheng-Yin T, Tankisi H, Tio-Gillen AP, Sedano Tous MJ, Verboon C, Vermeij FH, Visser LH, Huizinga R, Willison HJ, Jacobs BC.

IGOS Consortium. An International Perspective on Preceding Infections in Guillain-Barré Syndrome.

Murakami K, Miyamoto K, Terayama A, Yoshikawa K, Kuwahara M, Ito H.

Acute eye movement-retained internal ophthalmoplegia in atypical Miller Fisher syndrome variants are associated with IgG anti-GQ1b antibodies.

Suzuki S, Masuda M, Uzawa A, Nagane Y, Konno S, Suzuki Y, Kubota T, Sugimoto T, Samukawa M, Watanabe G, Ishizuchi K., Akamine H, Onishi Y, Yoshizumi K, Uchi T, Amino I, Ueta Y, Minami N, Kawaguchi N, Kimura T, Takahashi M P., Murai H, Utsugisawa K.

Japan MG registry: Chronological surveys over 10 years.

Omura S, Shimizu K, Kuwahara M, Morikawa-Urase M, Kusunoki S, Tsunoda I.

Exploratory factor analysis determines latent factors in Guillain-Barré-syndrome.

Nakano N, Miyauchi M, Nakagawa N, Mitsui Y, Tsuji K, Fukawa N, Takahashi J.

Task-specific dystonia in hairdressers : a questionnaire survey and review of the literature.

Murakami K, Miyamoto K, Terayama A, Yoshikawa K, Kuwahara M, Ito H.

Acute eye movement-retained internal ophthalmoplegia in atypical Miller Fisher syndrome variants are associated with IgG anti-GQ1b antibodies.

Suzuki M, Sango K, Nagai Y.

Roles of α-synuclein and disease-associated factors in Drosophila models of Parkinson’s disease.

Takeuchi T, Nagai Y.

Emerging roles of extracellular vesicles in polyglutamine diseases: mutant protein transmission, therapeutic

上田哲大, 武内敏秀, 永井義隆

神経変性疾患におけるRNA結合タンパク質凝集とarchitectural RNA

武内敏秀, 永井義隆

Exosomeと疾患　脊髄小脳変性症

富岡郁夫, 永井義隆, 関 和彦

Tripletリピート病モデルマーモセット

桑原　基.

CIDPの病型と診断

寒川　真.

補体標的薬（エクリズマブ）をどのように用いるか

寒川　真.

エクリズマブの作用機序, 有効性, 適応となる患者像